Interpharm Holdings (Interpharm Holdings) EBIT : $-19.72 Mil (TTM As of Dec. 2007)

Interpharm Holdings EBIT Chart

Interpharm Holdings Annual Data
	Trend	Jun98	Jun99	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07
EBIT		Get a 7-Day Free Trial					-	5.06	-0.10	-4.77	-10.74

Interpharm Holdings Quarterly Data
	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07
EBIT	Get a 7-Day Free Trial															-4.02	-2.25	-7.37	-6.15	-3.94

Competitive Comparison of Interpharm Holdings's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Interpharm Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Interpharm Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Interpharm Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Interpharm Holdings's EV-to-EBIT falls into.

Interpharm Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $-19.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interpharm Holdings  (GREY:IPAH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Interpharm Holdings's annualized ROC % for the quarter that ended in Dec. 2007 is calculated as:

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2007) data.

2. Joel Greenblatt's definition of Return on Capital:

Interpharm Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2007 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2007) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Interpharm Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interpharm Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Interpharm Holdings (Interpharm Holdings) Business Description